- All
- Post
- Page
Webinar – Injecting Insight: Analyzing GLP-1 Agonist Use and Opportunities for Optimal Management Within an Integrated Health System Specialty Pharmacy
Injecting Insight: Analyzing GLP-1 Agonist Use and Opportunities for Optimal Management Within an Integrated Health System Specialty Pharmacy According to the CDC, approximately 38 million Americans have diabetes and approximately…
Shields Health Solutions Partners with Major Academic Medical Center to Expand Specialty Pharmacy Services
STOUGHTON, Mass. (May 13, 2025)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced it has partnered with Duke Health, a leading academic health system in North…
DRAFT_Ceros
Patient Experience and Patient Outcomes: A Comprehensive Guide
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Patient Experience and Patient Outcomes: A Comprehensive Guide
Specialty Pharmacy Patient Experience and Patient Outcomes: A Comprehensive Guide Shields Health Solutions 11 min read Table of contents Contact Us Overview: Patient experience and patient outcomes, while two unique…
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…
Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2024 marked its 20th anniversary — and we couldn’t be…